利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

859 条记录 (耗时 0.024 秒)

    Process and apparatus for producing inorganic fullerene-like nanoparticles
    41.
    发明授权
    Process and apparatus for producing inorganic fullerene-like nanoparticles 有权
    用于生产无机富勒烯样纳米颗粒的方法和设备

    公开(公告)号：US07959891B2

    公开(公告)日：2011-06-14

    申请号：US12651912

    申请日：2010-01-04

    申请人： Reshef Tenne ,  Alexander Margolin ,  Ronit Popovitz-Biro ,  Lev Rapoport

    发明人： Reshef Tenne ,  Alexander Margolin ,  Ronit Popovitz-Biro ,  Lev Rapoport

    IPC分类号： C01B17/00 ,  C01B19/00 ,  C10M125/22

    CPC分类号： B01J19/0013 ,  B01J2219/182 ,  B82Y30/00 ,  C01B19/007 ,  C01G1/12 ,  C01G23/007 ,  C01G39/06 ,  C01G41/00 ,  C01P2004/34 ,  C01P2004/62 ,  C01P2004/64 ,  Y10S977/734 ,  Y10S977/773 ,  Y10S977/775 ,  Y10S977/81

    摘要： The present invention provides a process for obtaining fullerene-like metal chalcogenide nanoparticles, comprising feeding a metal precursor selected from metal halide, metal carbonyl, organo-metallic compound and metal oxyhalide vapor into a reaction chamber towards a reaction zone to interact with a flow of at least one chalcogen material in gas phase, the temperature conditions in said reaction zone being such to enable the formation of the fullerene-like metal chalcogenide nanoparticles product. The present invention further provides novel IF metal chalcogenides nanoparticles with spherical shape and optionally having a very small or no hollow core exhibiting excellent tribological behaviour. The present invention further provides an apparatus for preparing various IF nanostructures.

    摘要翻译： 本发明提供了一种获得富勒烯金属硫族化物纳米颗粒的方法，包括将选自金属卤化物，金属羰基，有机金属化合物和金属卤氧化物蒸气的金属前体进料到反应室中，使其与反应区相互作用， 在气相中的至少一种硫属元素材料，所述反应区中的温度条件使得能够形成富勒烯样金属硫族化物纳米颗粒产物。 本发明还提供具有球形形状的新型IF金属硫族化物纳米颗粒，并且任选地具有非常小的或不具有优异的摩擦学行为的中空芯。 本发明还提供了一种用于制备各种IF纳米结构的装置。

    POLYHYDROXYALKANOATES FOR IN VIVO APPLICATIONS
    42.
    发明申请
    POLYHYDROXYALKANOATES FOR IN VIVO APPLICATIONS 有权
    用于生殖器官应用的聚羟基烷酸酯

    公开(公告)号：US20110135707A1

    公开(公告)日：2011-06-09

    申请号：US13021419

    申请日：2011-02-04

    申请人： Simon F. Williams ,  David P. Martin ,  Tillman Gerngross ,  Daniel M. Horowitz

    发明人： Simon F. Williams ,  David P. Martin ,  Tillman Gerngross ,  Daniel M. Horowitz

    IPC分类号： A61F2/28 ,  C12N5/07 ,  A61F2/00 ,  A61K9/00 ,  A61K49/00 ,  A61K38/02 ,  A61K31/7088 ,  A61K31/715 ,  A61K31/70 ,  A61K31/20 ,  A61K9/70 ,  A61P17/02 ,  A61P19/08 ,  A61P9/00 ,  C08G63/91 ,  B32B1/08

    CPC分类号： C12P7/625 ,  A61B17/06166 ,  A61B42/00 ,  A61K47/593 ,  A61K47/6957 ,  A61L15/26 ,  A61L17/10 ,  A61L27/18 ,  A61L27/34 ,  A61L29/06 ,  A61L31/06 ,  C08G63/06 ,  C08G63/6852 ,  C08G63/6882 ,  C08G63/912 ,  C12N5/0068 ,  C12N2533/30 ,  Y10S977/775 ,  Y10T428/139 ,  C08L67/04

    摘要： Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided for use in numerous biomedical applications. PHAs which have been chemically modified to enhance physical and/or chemical properties, for targeting or to modify biodegradability or clearance by the reticuloendothelial system (RES), are described. Methods for depyrogenating PHA polymers prepared by bacterial fermentation processes are also provided, wherein pyrogens are removed from the polymers without adversely impacting the polymers' inherent chemical structures and physical properties. PHAs with advantageous processing characteristics, including low melting points and/or solubility in non-toxic solvents, are also described. PHAs are provided which are suitable for use in in vivo applications such as in tissue coatings, stents, sutures, tubing, bone and other prostheses, bone or tissue cements, tissue regeneration devices, wound dressings, drug delivery, and for diagnostic and prophylactic uses. Properties which are selected for include degradability, elasticity, inclusion of functional groups or derivatized groups, which can in turn be used to attach targeting agents, and bioadhesion.

    摘要翻译： 已经除去热原的聚羟基链烷酸酯（PHA）被提供用于许多生物医学应用。 已经化学改性以增强物理和/或化学性质的PHA用于通过网状内皮系统（RES）靶向或修饰生物降解性或清除的PHA。 还提供了通过细菌发酵方法制备的PHA聚合物去热原化方法，其中热原从聚合物中除去而不会不利地影响聚合物固有的化学结构和物理性质。 还描述了具有有利处理特性的PHA，包括低熔点和/或在无毒溶剂中的溶解度。 提供适用于体内应用的PHA，例如在组织涂层，支架，缝线，管，骨和其他假体，骨或组织水泥，组织再生装置，伤口敷料，药物递送以及用于诊断和预防用途 。 选择的性质包括降解性，弹性，包含官能团或衍生基团，其又可用于附着靶向剂，以及生物粘附。

    Metal oxide-containing nanoparticles
    45.
    发明授权
    Metal oxide-containing nanoparticles 有权
    含金属氧化物的纳米粒子

    公开(公告)号：US07901656B2

    公开(公告)日：2011-03-08

    申请号：US10549950

    申请日：2004-03-19

    申请人： Charles H. Winter ,  Charles L. Dezelah, IV

    发明人： Charles H. Winter ,  Charles L. Dezelah, IV

    IPC分类号： C01B13/14 ,  C01G5/00 ,  C01G3/02 ,  C01G7/00

    CPC分类号： C01G3/02 ,  B82Y30/00 ,  C01G1/00 ,  C01G1/02 ,  C01P2002/72 ,  C01P2002/88 ,  C01P2004/04 ,  C01P2004/64 ,  C09C1/00 ,  C09C3/08 ,  H01L21/288 ,  H01L21/76838 ,  H01L21/76877 ,  Y10S977/762 ,  Y10S977/773 ,  Y10S977/775 ,  Y10S977/776

    摘要： The present invention provides a copper oxide-containing composition that includes copper oxide nanoparticles and one or more heteroatom donor ligands bonded to the surface of the nanoparticles, where x and y are numbers having a ratio that is equal to the ratio of the average number of M atoms to the average number of O atoms in the nanoparticles. The nanoparticles are stabilized by the one or more heteroatom donor ligands which act as a protective layer that cap the surface of the nanoparticles. The present invention also provides a solution of the copper oxide nanoparticles that may be applied to a substrate and then subsequently reduced to copper metal. Finally, the invention provides a method of preparing the copper oxide nanoparticles.

    摘要翻译： 本发明提供一种含氧化铜的组合物，其包含氧化铜纳米颗粒和结合到纳米颗粒表面的一个或多个杂原子供体配体，其中x和y是具有等于平均数 M原子与纳米颗粒中O原子的平均数目。 纳米颗粒被一个或多个杂原子供体配体稳定，其作为覆盖纳米颗粒表面的保护层。 本发明还提供可以施加到基底上然后还原成铜金属的氧化铜纳米颗粒的溶液。 最后，本发明提供一种制备氧化铜纳米颗粒的方法。

    Electrical circuit device having carbon nanotube fabrication from crystallography oriented catalyst
    46.
    发明授权
    Electrical circuit device having carbon nanotube fabrication from crystallography oriented catalyst 有权
    具有由晶体取向催化剂制造的碳纳米管的电路装置

    公开(公告)号：US07893423B2

    公开(公告)日：2011-02-22

    申请号：US12656200

    申请日：2010-01-21

    申请人： Vincent Gambin ,  Roger Su-Tsung Tsai

    发明人： Vincent Gambin ,  Roger Su-Tsung Tsai

    IPC分类号： H01L29/06

    CPC分类号： H01L21/02645 ,  B82Y10/00 ,  B82Y30/00 ,  B82Y40/00 ,  C01B32/162 ,  C01B2202/02 ,  H01L21/02381 ,  H01L21/02527 ,  H01L21/02606 ,  H01L51/0048 ,  H01L51/0545 ,  Y10S977/742 ,  Y10S977/763 ,  Y10S977/775 ,  Y10S977/938

    摘要： A device and method associated with carbon nanowires, such as single walled carbon nanowires having a high degree of alignment are set forth herein. A catalyst layer is deposited having a predetermined crystallographic configuration so as to control a growth parameter, such as an alignment direction, a diameter, a crystallinity and the like of the carbon nanowire. The catalyst layer is etched to expose a sidewall portion. The carbon nanowire is nucleated from the exposed sidewall portion. An electrical circuit device can include a single crystal substrate, such as Silicon, and a crystallographically oriented catalyst layer on the substrate having an exposed sidewall portion. In the device, carbon nanowires are disposed on the single crystal substrate aligned in a direction associated with the crystallographic properties of the catalyst layer.

    摘要翻译： 本文阐述了与碳纳米线相关联的装置和方法，例如具有高度对准的单壁碳纳米线。 沉积具有预定晶体结构的催化剂层，以便控制碳纳米线的生长参数，例如取向方向，直径，结晶度等。 蚀刻催化剂层以暴露侧壁部分。 碳纳米线从暴露的侧壁部分成核。 电路装置可以包括诸如硅的单晶衬底，以及在衬底上的具有暴露侧壁部分的晶体取向催化剂层。 在该器件中，碳纳米线设置在与催化剂层的结晶性质相关联的方向上排列的单晶衬底上。